← Back to Search

PLX-PAD for Acute Respiratory Distress Syndrome

Phase 2
Waitlist Available
Research Sponsored by Pluristem Ltd.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 28 days
Awards & highlights

Study Summary

This trial will study if a new treatment can help patients with COVID-19 recover more quickly with less complications.

Eligible Conditions
  • Coronavirus Disease
  • Acute Respiratory Distress Syndrome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~28 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 28 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of ventilator free days
Secondary outcome measures
All-cause mortality
Duration of mechanical ventilation

Trial Design

5Treatment groups
Experimental Treatment
Placebo Group
Group I: PLX-PAD low doseExperimental Treatment1 Intervention
PLX-PAD 300, single administration, second administration of placebo after 1 week.
Group II: PLX-PAD interval high doseExperimental Treatment1 Intervention
PLX-PAD will be administered via 15 IM injections (1 mL each). Each subject will be treated twice, with an interval of 1 week between treatments.
Group III: PLX-PAD high doseExperimental Treatment1 Intervention
PLX-PAD, single administration
Group IV: Control Group BPlacebo Group1 Intervention
Placebo, single administration
Group V: Control Group APlacebo Group1 Intervention
Placebo, two administrations, 1 week apart
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
PLX-PAD
2009
Completed Phase 3
~260

Find a Location

Who is running the clinical trial?

Pluristem Ltd.Lead Sponsor
10 Previous Clinical Trials
751 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Double-Blind, Multicenter, Study to Evaluate the Efficacy of PLX PAD for the Treatment of COVID-19
2020. "Double-Blind, Multicenter, Study to Evaluate the Efficacy of PLX PAD for the Treatment of COVID-19". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04389450.
~15 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top